Illumina Body Map 2
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_30648066 Show fit | 0.95 |
ENST00000359013.4
|
transforming growth factor, beta receptor II (70/80kDa) |
|
chr12_+_60083118 Show fit | 0.86 |
ENST00000261187.4
ENST00000543448.1 |
solute carrier family 16 (monocarboxylate transporter), member 7 |
|
chr18_+_905104 Show fit | 0.83 |
ENST00000579794.1
|
adenylate cyclase activating polypeptide 1 (pituitary) |
|
chr7_-_131241361 Show fit | 0.77 |
ENST00000378555.3
ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
podocalyxin-like |
|
chr7_+_3340989 Show fit | 0.77 |
ENST00000404826.2
ENST00000389531.3 |
sidekick cell adhesion molecule 1 |
|
chr11_-_86666427 Show fit | 0.76 |
ENST00000531380.1
|
frizzled family receptor 4 |
|
chr13_-_107187462 Show fit | 0.71 |
ENST00000245323.4
|
ephrin-B2 |
|
chr11_-_30038490 Show fit | 0.69 |
ENST00000328224.6
|
potassium voltage-gated channel, shaker-related subfamily, member 4 |
|
chr2_-_208030647 Show fit | 0.65 |
ENST00000309446.6
|
Kruppel-like factor 7 (ubiquitous) |
|
chr12_+_65004292 Show fit | 0.63 |
ENST00000542104.1
ENST00000336061.2 |
Ras association (RalGDS/AF-6) domain family member 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.1 | 0.9 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.3 | 0.8 | GO:0090274 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
0.3 | 0.8 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.2 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.0 | 0.8 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.7 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.6 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.0 | 0.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.1 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.9 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.2 | 0.9 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.0 | 0.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.6 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.0 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |